Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Amit, Singnurkar"'
Autor:
Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople, Nir Lipsman, Muhammad I. Husain, Joshua D. Rosenblat, Xingshan Cao, Bradley J. MacIntosh, Sean M. Nestor
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-19 (2024)
Abstract Background Major depressive disorder (MDD) is a leading cause of disability worldwide across domains of health and cognition, affecting overall quality of life. Approximately one third of individuals with depression do not fully respond to t
Externí odkaz:
https://doaj.org/article/8958465c86ef44d6807fc658be7eb838
Autor:
Amit Singnurkar, Anand Swaminath, Ur Metser, Deanna L. Langer, Gail E. Darling, Gregory R. Pond
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100246- (2020)
BACKGROUND: To determine if synchronous extrapulmonary malignancies in early stage lung cancer impact survival and cost of care in the current era of improved therapies and diagnostics. METHODS: Patients with stage I and II lung cancer were identifie
Externí odkaz:
https://doaj.org/article/cd3d5ed32cec4328b6e8aadc068839c2
Publikováno v:
Journal of Neuro-Oncology. 161:1-12
To provide a summary of the diagnostic performance ofMEDLINE, EMBASE, and Cochrane Database of Systematic Reviews databases were searched for studies that reported on diagnostic test parameters in radiotherapy planning, response assessment, and tumou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc7b3bb022cfc07e117e2b7c9a16840
https://doi.org/10.1007/s11060-022-04201-6
https://doi.org/10.1007/s11060-022-04201-6
Autor:
James Perry, Ying Meng, Rossanna C. Pezo, Sten Myrehaug, Clement Hamani, Chinthaka Hyen, Arjun Sahgal, Benjamin Davidson, Raymond M. Reilly, Yuexi Huang, Suganth Suppiah, Amit Singnurkar, Nir Lipsman, Maheleth Llinas, Kullervo Hynynen, Christopher B Pople, Maureen E. Trudeau
Publikováno v:
Science translational medicine. 13(615)
The blood-brain barrier (BBB) is an important factor limiting the effectiveness of central nervous system (CNS) therapeutics. MR-guided focused ultrasound (MRgFUS) is a noninvasive, spatially precise technology that enhances drug delivery across a te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8588774d270b448f1598b4af2196d835
https://pubmed.ncbi.nlm.nih.gov/34644145
https://pubmed.ncbi.nlm.nih.gov/34644145
Autor:
Maria Eberg, Anca Prica, Jill Dudebout, Bo Green, Mindaugas Mozuraitis, Victor Mak, David C. Hodgson, Noam Tau, Pamela MacCrostie, Deanna L. Langer, Amit Singnurkar, Ur Metser, Nicole Mittmann
Publikováno v:
Radiology. 290:488-495
Purpose To determine the relationship of PET/CT staging to the management and outcomes of participants with apparent limited-stage (LS) Hodgkin lymphoma (HL) or aggressive non-HL (ANHL) treated with curative intent. Materials and Methods This prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05d7f39f3ff70d636e469295a05a6cb
https://doi.org/10.1148/radiol.2018181519
https://doi.org/10.1148/radiol.2018181519
Publikováno v:
Medical Imaging for Health Professionals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c4445ba45b8f83589595c4a45dff046
https://doi.org/10.1002/9781119537397.ch15
https://doi.org/10.1002/9781119537397.ch15
Publikováno v:
Clinical Nuclear Medicine. 41:189-193
PURPOSE The Ontario PET Registry was established to provide evidence on the clinical impact of 18-FDG-PET/CT (PET) imaging to inform Ontario Health Insurance Plan funding decisions. The melanoma registry assessed the use of melanoma staging by PET in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be889a9be84ba76985ccc48ccb7cc863
https://doi.org/10.1097/rlu.0000000000000996
https://doi.org/10.1097/rlu.0000000000000996
Autor:
Rosalyn A. Juergens, Katherine A. Zukotynski, Amit Singnurkar, Denis P. Snider, John F. Valliant, Karen Y. Gulenchyn
Publikováno v:
Biomarkers in Cancer, Vol 2016, Iss Suppl. 2, Pp 1-13 (2016)
Biomarkers in Cancer, Vol 8s2 (2016)
Biomarkers in Cancer, Vol 8s2 (2016)
Immune-based therapies have been in use for decades but recent work with immune checkpoint inhibitors has now changed the landscape of cancer treatment as a whole. While these advances are encouraging, clinicians still do not have a consistent biomar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9362fa0f912ea1c4db844a8db56a4281
http://www.la-press.com/imaging-biomarkers-in-immunotherapy-article-a5418
http://www.la-press.com/imaging-biomarkers-in-immunotherapy-article-a5418
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100246-(2020)
BACKGROUND To determine if synchronous extrapulmonary malignancies in early stage lung cancer impact survival and cost of care in the current era of improved therapies and diagnostics. METHODS Patients with stage I and II lung cancer were identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a3bc577ffd5787472464f5c189e370
https://doi.org/10.1016/j.ctarc.2020.100246
https://doi.org/10.1016/j.ctarc.2020.100246